Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wesolowski

Showing results (851-860 of 945) with videos related to

Pageof 95
Sort By:
Langmuir : the ACS Journal of Surfaces and Colloids|June 30, 2005
Ion adsorption at the rutile-water interface: linking molecular and macroscopic propertiesZ Zhang, P Fenter, L Cheng, et al.
Journal of Medicinal Chemistry|September 25, 2008
Identification of a nonbasic, nitrile-containing cathepsin K inhibitor (MK-1256) that is efficacious in a monkey model of osteoporosisJöel Robichaud, W Cameron Black, Michel Thérien, et al.
Journal of Medicinal Chemistry|February 3, 2006
Beta-substituted cyclohexanecarboxamide: a nonpeptidic framework for the design of potent inhibitors of cathepsin KSheldon N Crane, W Cameron Black, James T Palmer, et al.
Therapeutic Advances in Medical Oncology|June 12, 2025
Impact of low hormone receptor expression on neoadjuvant chemotherapy response and patterns of care in non-metastatic HER2-negative breast cancer: a US National Cancer Database analysisDionisia Quiroga, Charles Pei, Julie A Stephens, et al.
Journal of Medicinal Chemistry|October 6, 2000
Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonistM E Duggan, L T Duong, J E Fisher, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|June 19, 2023
Worry and Mindfulness Differentially Impact Symptom Burden Following Treatment Among Breast Cancer Survivors: Findings From a Randomized Crossover TrialMegan E Renna, Annelise A Madison, Juan Peng, et al.
Frontiers in Endocrinology|August 8, 2024
Analysis of beta-cell maturity and mitochondrial morphology in juvenile non-human primates exposed to maternal Western-style diet during developmentDarian T Carroll, Allie Miller, Jennifer Fuhr, et al.
American Journal of Obstetrics and Gynecology|June 13, 2024
Initiation of metformin in early pregnancy results in fetal bioaccumulation, growth restriction, and renal dysmorphology in a primate modelErin Bolte, Tyler Dean, Brandon Garcia, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2006
Identification of a potent and selective non-basic cathepsin K inhibitorChun Sing Li, Denis Deschenes, Sylvie Desmarais, et al.
Menopause (New York, N.Y.)|February 3, 2021
Patient-reported sexual function of breast cancer survivors with genitourinary syndrome of menopause after fractional CO2 laser therapyAllison M Quick, Filadelfiya Zvinovski, Catherine Hudson, et al.
Pageof 95

Showing results (851-860 of 945) with videos related to

Sort By:
Pageof 95
Langmuir : the ACS Journal of Surfaces and Colloids|June 30, 2005
Ion adsorption at the rutile-water interface: linking molecular and macroscopic propertiesZ Zhang, P Fenter, L Cheng, et al.
Journal of Medicinal Chemistry|September 25, 2008
Identification of a nonbasic, nitrile-containing cathepsin K inhibitor (MK-1256) that is efficacious in a monkey model of osteoporosisJöel Robichaud, W Cameron Black, Michel Thérien, et al.
Journal of Medicinal Chemistry|February 3, 2006
Beta-substituted cyclohexanecarboxamide: a nonpeptidic framework for the design of potent inhibitors of cathepsin KSheldon N Crane, W Cameron Black, James T Palmer, et al.
Therapeutic Advances in Medical Oncology|June 12, 2025
Impact of low hormone receptor expression on neoadjuvant chemotherapy response and patterns of care in non-metastatic HER2-negative breast cancer: a US National Cancer Database analysisDionisia Quiroga, Charles Pei, Julie A Stephens, et al.
Journal of Medicinal Chemistry|October 6, 2000
Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonistM E Duggan, L T Duong, J E Fisher, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|June 19, 2023
Worry and Mindfulness Differentially Impact Symptom Burden Following Treatment Among Breast Cancer Survivors: Findings From a Randomized Crossover TrialMegan E Renna, Annelise A Madison, Juan Peng, et al.
Frontiers in Endocrinology|August 8, 2024
Analysis of beta-cell maturity and mitochondrial morphology in juvenile non-human primates exposed to maternal Western-style diet during developmentDarian T Carroll, Allie Miller, Jennifer Fuhr, et al.
American Journal of Obstetrics and Gynecology|June 13, 2024
Initiation of metformin in early pregnancy results in fetal bioaccumulation, growth restriction, and renal dysmorphology in a primate modelErin Bolte, Tyler Dean, Brandon Garcia, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2006
Identification of a potent and selective non-basic cathepsin K inhibitorChun Sing Li, Denis Deschenes, Sylvie Desmarais, et al.
Menopause (New York, N.Y.)|February 3, 2021
Patient-reported sexual function of breast cancer survivors with genitourinary syndrome of menopause after fractional CO2 laser therapyAllison M Quick, Filadelfiya Zvinovski, Catherine Hudson, et al.
Pageof 95